CHASITY BIGGERSTAFF: Open Payments
NPI 1225811326 · COLUMBIA, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$691 in 34 payments from 10 companies in 2025. Trend: 2023 $18 · 2024 $143 · 2025 $691
Food & beverage: $691
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $171 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $136 |
| Novo Nordisk Inc | 4 | $78 |
| ABBVIE INC. | 4 | $68 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $51 |
| GlaxoSmithKline, LLC. | 3 | $50 |
| Vanda Pharmaceuticals Inc. | 2 | $35 |
| Amgen Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $17 |
Products named: BREZTRI, CAPLYTA, VOQUEZNA, MOUNJARO, TRELEGY ELLIPTA, VRAYLAR, FANAPT, QULIPTA.
Industry payments across KY — which companies pay providers there.
